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Common iliac artery aneurysm: Expansion
rate and results of open surgical
and endovascular repair
Ying Huang, MD, PhD, Peter Gloviczki, MD, Audra A. Duncan, MD, Manju Kalra, MBBS,
Tanya L. Hoskin, MS, Gustavo S. Oderich, MD, Michael A. McKusick, MD,
and Thomas C. Bower, MD, Rochester, Minn
Objectives: To assess expansion rate of common iliac artery aneurysms (CIAAs) and define outcomes after open repair
(OR) and endovascular repair (EVAR).
Methods: Clinical data of 438 patients with 715 CIAAs treated between 1986 and 2005 were retrospectively reviewed.
Size, presentations, treatments, and outcomes were recorded. Kaplan-Meier method with log-rank tests and 2 test were
used for analysis.
Results: Interventions for 715 CIAAs (median, 4 cm; range, 2-13 cm) were done in 512 men (94%) and 26 women (6%);
152 (35%) had unilateral and 286 (65%) had bilateral CIAAs. Group 1 comprised 377 patients (633 CIAAs) with current
or previously repaired abdominal aortic aneurysm (AAA). Group 2 comprised 15 patients (24 CIAAs) with associated
internal iliac artery aneurysm (IIAA). Group 3 comprised 46 patients (58 isolated CIAAs). Median expansion rate of 104
CIAAs with at least two imaging studies was 0.29 cm/y; hypertension predicted faster expansion (0.32 vs 0.14 cm/y, P
.01). A total of 175 patients (29%) were symptomatic. The CIAA ruptured in 22 patients (5%, median, 6 cm; range,
3.8-8.5 cm), and the associated AAA ruptured in 20 (4%). Six (27%) ilioiliac or iliocaval fistulas developed. Repairs were
elective in 396 patients (90%) and emergencies in 42 (10%). OR was performed in 394 patients (90%) and EVAR in 44
(10%). The groups had similar 30-day mortality: 1% for elective, 27% for emergency repairs (P < .001); 4% after OR
(elective, 1%; emergency, 26%), and 0% after EVAR. No deaths occurred after OR of arteriovenous fistula. Complications
were more frequent and hospitalization was longer after OR than EVAR (P< .05). Mean follow-up was 3.7 years (range,
1 month-17.5 years). The groups had similar 5-year primary (95%) and secondary patency rates (99.6%). At 3 years,
secondary patency was 99.6% for OR and 100% for EVAR (P  .66); freedom from reintervention was similar after OR
and EVAR (83% vs 69%, P  .17), as were survival rates (76% vs 77%, P  .70).
Conclusions: The expansion rate of CIAAs is 0.29 cm/y, and hypertension predicts faster expansion. Because no rupture
of a CIAA<3.8 cm was observed, elective repair of asymptomatic patients with CIAA>3.5 cm seems justified. Although
buttock claudication after EVAR remains a concern, results at 3 years support EVAR as a first-line treatment for most
anatomically suitable patients who require CIAA repair. Patients with compressive symptoms or those with AVF should
preferentially be treated with OR. (J Vasc Surg 2008;47:1203-11.)Iliac artery aneurysms (IAAs) are the most frequent
aneurysms after abdominal aortic aneurysms (AAAs), and
common iliac artery aneurysms (CIAAs) are the most com-
mon IAAs.1 Most CIAAs develop in patients with AAA,
and isolated IAAs are rare, constituting only about 2% of all
abdominal aneurysms.2,3
Similar to AAAs, CIAAs are more prone to rupture
when they reach a critical size; unfortunately, data on the
natural history of untreated CIAAs are scarce. McCready et
al1 observed a growth rate of 4 mm/y and recommended
repair when they reached 3 cm in size. Santilli et al4 studied
the rate of growth of isolated IAAs, mostly CIAAs. IAAs
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whereas those 3 cm expanded by 2.6 mm/y. Because
symptoms, including rupture, did not develop with IAAs
4 cm in diameter, the authors suggested repair for aneu-
rysms 3.5 cm in size.4
Open surgical repair (OR) with prosthetic grafts has
long been the gold standard of treatment of CIAAs, and
results have improved during the past decades.1,3-10 With
the development of endovascular techniques, an increasing
number of reports have been published on stent graft repair
of CIAAs with good early- and mid-term results.11-22 At
some institutions, endovascular repair (EVAR) and not OR
is now offered preferentially to patients with IAAs.23
The purpose of this study was to define expansion rate
in a larger number of patients with CIAAs and to evaluate
outcomes after OR and EVAR in patients with or without
associated AAA in a contemporary series at a tertiary insti-
tution.
METHODS
The clinical records of patients with the diagnosis of
CIAA seen at the Mayo Clinic, Rochester, Minnesota,
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retrospectively reviewed. The data of 438 patients who
underwent interventions for 715 CIAAs were analyzed.
A CIAAwas defined as a permanent localized dilatation
2.0 cm in size and an AAA 3.5 cm, measured by
ultrasonography (US), computed tomography (CT) scan,
magnetic resonance (MR) imaging, angiography, or docu-
mented by surgical records. The maximum transverse an-
eurysm diameter was recorded. Patients with interventions
for CIAA were divided into three groups: group 1 included
patients with CIAA who also had AAA, group 2 included
patients with CIAA and internal iliac artery aneurysm
(IIAA), and group 3 included those with isolated CIAA. In
group 1, only patients who had at least one CIAA with a
diameter of 3.5 cm were included, and treatment of the
CIAA alone was justified. In groups 2 and 3, patients
were included with a CIAA 2.0 cm in size. Patients with
the diagnosis of common iliac artery pseudoaneurysms or
dissections were excluded. Expansion rate of aneurysms was
studied in patients who had 2 US or CT scans before
repair.
Cardiac, pulmonary, and renal risk factors were doc-
umented using criteria of the Department of Veterans
Affairs National Surgical Quality Improvement Program
(NSQIP).24 Criteria for high surgical risks were defined in
our previous report.25
Indications for repair in group 1 included rupture or
symptoms of CIAA, previous embolic events, or size 3.5
cm. In groups 2 and 3, seven patients with nine asymptom-
atic CIAAs underwent repair with aneurysm sized3.5 cm,
and 28 patients with 33 asymptomatic CIAAs 3.5 cm
were treated. Criteria for EVAR (after 2001) were ana-
tomic suitability and surgeon and patient preference. The
most frequent techniques for OR are presented in Fig 1,A;
excision, ligation, or endoaneurysmorrhaphy were also
used selectively. In some patients, extra-anatomic ilioiliac
or femorofemoral bypass was performed.
Endovascular repair included aortobiiliac stent grafts or
straight iliac endografts (Fig 1, B), usually with emboliza-
tion of the internal iliac artery (IIA) or IIAA. Bypass from
the external iliac artery (EIA) or femoral artery to IIA was
performed in some patients to preserve pelvic circulation.
Patients were asked to return at 3 months for physical
examination and US imaging, and every 6 months after-
wards. Patients with EVAR were monitored with CT scan-
ning every 6 months. Patency and presence of endoleaks
were determined by imaging studies. Follow-up informa-
tion, including reinterventions, was obtained from the
medical records and by mailed questionnaires. The study
was approved by the Mayo Foundation Institutional Re-
view Board.
Descriptive statistics, including means, standard devia-
tions, ranges, and proportions were calculated as appropri-
ate. The paired t test was used in right and left aneurysm
size analysis. Patency, reintervention, and survival were
calculated using the Kaplan-Meier method. Log-rank tests
were used to compare survival and reintervention rates
between groups as well as survival of our study cohort withthe expected survival rate for an age- and sex-matched
cohort from the United States population. Cox propor-
tional hazards regression and multivariable analyses were
used for survival comparisons. Analyses were performed
using SAS 9 software (SAS Institute Inc, Cary, NC).
RESULTS
Demographic data. Between 1986 and 2005, 1711
patients were diagnosed with 2637 CIAAs at the Mayo
Clinic, Rochester, Minnesota. Of these, 438 underwent
interventions (Table I) for 715 CIAAs, 382 right (53%),
and 333 left (47%); 377 patients (86%) also had AAA, and
286 (65%) had contralateral CIAA. A total of 128 patients
(29%) had IIAA (unilateral, 82; bilateral, 46), and 11 (3%)
had external IAA (unilateral, 10; bilateral, 1).
Group 1 included 377 patients (86%) with 633 CIAAs
(89%); 327 (87%) had concurrent AAA and 50 (13%) had
previously repaired AAA. Group 2 included 15 patients
(3%) with 24 CIAAs (3%). Group 3 included 46 patients
(11%) with 58 CIAAs (8%), of which 12 patients (25%) had
bilateral CIAAs compared with 265 in group 1 (70%) and
nine in group 2 (60%; P  .001). Of 11 patients with
external IAA, 10 were classified into group 1 and one into
group 2; six of these patients had IIAA. IIAA was more
frequent in patients with bilateral vs unilateral CIAAs (37%
Fig 1. Interventions. A, Open repair with bifurcated or straight
polyester graft in 380 patients. B, Endovascular repair with bifur-
cated or straight stent grafts in 41 patients.[105 of 286] vs 15% [23 of 152], P  .001).
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aging studies: 535 (77%) had CT scan or CT angiography,
326 (47%) had US, 229 (33%) had contrast aortography,
and 29 (4%) had MR angiography. Size was available for
668 CIAAs (93%), and the median diameter was 4 cm
(range, 2-13 cm; Appendix Table I, online only). In pa-
tients with bilateral CIAAs, the right aneurysm was larger
than the left (median, 4.2 cm [range, 2-13 cm] vs 3.6 cm
[range, 2-9 cm] P  .001). Median diameter of 22 rup-
tured CIAAs was 6 cm (range, 3.8-8.5 cm; Appendix Table
I, online only). The smallest aneurysm that ruptured was
3.8 cm. Six CIAAs (27%; median, 5 cm [range, 3.8-8.5
cm]), all in group 1, ruptured into the iliac vein or inferior
vena cava (right, 5; left, 1).
Expansion rate. Seventy-two patients with 104
CIAAs had at least two US or CT scans. Median expansion
rate was 0.29 cm/y (Table II). Hypertension predicted
faster expansion (0.32 cm/y vs 0.14 cm/y, P  .01).
Clinical presentation. A total of 125 patients (29%)
were symptomatic; abdominal or lower quadrant pain was
the most frequent symptom (56%; Table III). Two patients
had acute deep vein thrombosis (DVT), and 11 had chronic
DVT. Forty-five aneurysms ruptured.
Intraoperative data. Repairs were elective in 396 pa-
tients (90%). Emergency repair was done in 42 (10%) for
aneurysm rupture in 40 patients (OR, 18 ruptured CIAAs,
18 ruptured AAAs, 3 ruptured pseudoaneurysms; EVAR, 1
ruptured AAA), and two symptomatic CIAAs. Elective
repair was done in five patients with ruptured aneurysms,
comprising three arteriovenous fistulas (AVFs,) one iliac,
and one AAA rupture.
Open repair was done in 394 patients (90%) for 648
(91%) CIAAs; 384 patients also had revascularization of the
affected limb; 380 had bifurcated or straight polyester
grafts (Fig 1, A), 3 had a femorofemoral crossover graft
placed, and 1 patient had CIAA resection with reanastomo-
sis of the common to external IA. For the remaining 10
patients, 7 had previous AAA repair with aortobifemoral
Table I. Demographic data and risk factors of 438
patients with common iliac artery aneurysms
Variable Value
Patients, No. (%) 438 (100)
Sex, No. (%)
Male 412 (94)
Female 26 (6)
Age, years
Mean  SD 72  7
Median (range) 73 (47-91)
Cardiovascular risk factors, No. (%)a 213 (49)
Pulmonary risk factors, No. (%)a 121 (28)
Renal risk factors, No. (%)a 42 (10)
Hypertension, No. (%) 304 (69)
Diabetes mellitus, No. (%) 45 (10)
Current smokers, No. (%) 96 (22)
aAs defined by the National VA Surgical Quality Improvement Program.24bypass grafts, endoaneurysmorrhaphy of CIAA was per-formed on 6 and ligation on 1; 1 patient had one-stage
CIAA ligation and ipsilateral external hemipelvectomy.
Two patients with ruptured AAA died during emergency
abdominal exploration.
The IIA was revascularized in 56 cases with separate
bypass grafts. The inferior mesenteric artery (IMA) was
reimplanted in 40 patients. Seven patients (group 1, 2%)
underwent thoracolaparotomy for repair of an associated
thoracoabdominal aneurysm.
Endovascular treatment was performed on 44 patients
(10%), 41 with stent grafts (Fig 1, B) and 3 with coil
embolization alone; 43 had elective, and 1 had emergency
repair. Stent grafts used included 30 AneuRx (Medtronic
Inc, Santa Rosa, Calif), 7 Gore Excluder (W. L. Gore &
Associates Inc, Flagstaff, Ariz), 1 Zenith (Cook Medical
Inc, Bloomington, Ind), 1 Ancure (Guidant Corp, India-
napolis, IN), 1 Wall graft (Boston Scientific Corp, Natick,
MA), and 1 AneuRx-Zenith combination. Thirty-two pa-
tients had IIA (n 19) or IIAA (n 13) coil embolization,
10 preoperatively and 22 intraoperatively (Fig 1, B). Three
patients with EVAR underwent IIA reconstruction with
EIA to IIA bypass (n  2) or superficial femoral artery to
IIA bypass (n  1). There was no conversion to OR.
Simultaneous IIAA exclusion was performed in 97 of
128 patients (76%) for 109 of 174 IIAAs (63%), consisting
of ligation in 44, endoaneurysmorrhaphy in 40, excision in
12, and embolization in 13.Median operative time was 271
minutes (range, 24-710 minutes) and was longer with OR
at 285 minutes vs EVAR at 172 minutes (P  .002).
Histologic study was performed in 291 patients (66%);
of which 280 (96%) had degenerative atherosclerosis, eight
aneurysms (3%) were inflammatory and fibromuscular dys-
plasia (FMD) was present in three (1%). According to
imaging, surgical and pathological records, 21 patients
(5%) had inflammatory CIAA.
Early Results
Mortality. The 30 day mortality was 3% (n  15),
occurring after four elective (1%) and 11 (27%) emergency
ORs (P  .001). There was no difference among groups
(group 1, 12 [3%]; group 2, 0; group 3, 3 [7%], P  .93).
No deaths occurred after OR of iliac AVF and EVAR. For
elective repair there was no significant difference in mortal-
ity between high- and low-risk patients at 30 days (2% vs
1%, P  .30).
Morbidity. Major complications occurred in 23% of
patients, more frequently after emergency than elective
repair (P .05; Table IV). The groups had similar morbid-
ity at 30 days. Pulmonary complications were significantly
more frequent in high-risk patients (21% vs 13%, P .03).
Clinically significant ischemic colitis developed in four pa-
tients (1%), two after emergency, and two after elective
repairs; none had revascularization of the IIAs, and both
IIAs were ligated in one patient. Two patients had ischemic
injury to the spinal cord, one after thoracoabdominal re-
pair, the other after elective OR using a bifurcated polyester
graft with ligation of both IIAs and reimplantation of IMA.
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days were 99.4% 0.3% and 100%, respectively. There was
no difference among groups or between OR and EVAR.
Two prosthetic grafts and two stent grafts thrombosed.
Both were recanalized with thrombectomy (n  2) or
thrombolysis (n  2), with an additional stent graft place-
ment in one.
Endoleak. Thirteen patients (31%) had endoleak at
discharge (type I, 1; type II, 9; both, 1; type IV, 1; un-
known, 1), resulting in 90% freedom from non-type II
endoleak and 78% freedom from type II endoleak.
Hospital length of stay. Median ICU and hospital
lengths of stay were shorter for patients with EVAR (0 and
2 days) vs those with OR (3 and 10 days, P  .001). The
days were similar in all 3 groups.
Late Results
Survival. Five-year survival rate was 65%  3%, not
different between groups, but less than the expected 76%
survival of the United States population matched for age
and sex (P  .001). Survival was higher in patients with
elective vs emergency repair (68%  3% vs 34%  8%, P 
.001). Three-year survival was similar in patients with OR
and with EVAR (Fig 2). Univariate analysis revealed rup-
ture was the best predictor of decreased survival (P .001;
Table II. Median expansion rate of 104 common iliac art
Aneurysm type
Expans
2.5 (23) 2.5-2.9 (28)
CIAA
With AAA 0.26 (22) 0.26 (26)
No AAA 0.72 (1) 0.84 (2)
Overall 0.26 0.26
CIAA, common iliac artery aneurysm; AAA, abdominal aortic aneurysm.
aP  .48 between CIAA with AAA and without AAA or between size grou
Table III. Clinical presentation of 438 patients with com
Group 1, No. (%)
Total patients 377
Asymptomatic 277 (71)
Symptomatic 100 (29)
Abdominal/lower quadrant/back pain 61 (16)
Claudication 22 (6)
Lower extremity edemab 53 (8)b
Urinary symptoms 6 (2)
Rupture 36 (10)
CIAA rupture 14 (4)
AAA rupture 20 (5)
False aneurysm rupture 2 (1)
AAA, abdominal aortic aneurysm; CIAA, common iliac artery aneurysm; G
Group 3, isolated CIAA.
aP  .05 among 3 groups.
bCalculation based on per limb: group 1, 633; group 2, 24; group 3, 58; o
cOne contained AAA rupture and one arteriovenous fistula was asymptoma
dTwo aortic pseudoaneurysms and one external iliac artery pseudoaneurysmAppendix Table II, online). In multivariate analysis, emer-gency intervention, chronic obstructive pulmonary disease
(COPD), and age remained significant predictors (P 
.01), with respective hazard ratios (95% confidence inter-
vals) of 2.55 (1.75-3.70), 1.96 (1.49-2.56), and 153
(1.19-1.98). No late rupture of an aneurysmwas identified.
Patency. During amean follow-up of 3.7 years (range,
1month-17.5 years), 5-year primary and secondary patency
rates for the entire cohort were 95%  1% and 99.6% 
0.3%, respectively. There was no difference in patency
among three groups. Five-year primary patency rates after
OR were higher with elective (97%  1%) vs emergency
repair (73% 12%, P .03; Appendix Fig 1, online only).
At 3 years, primary patency rates were equivalent for OR
(97% 1%) vs EVAR (95% 3%, P .11; Appendix Fig 2,
online only), and there was also no difference between
secondary patency, at 99.6%  0.3% for OR and 100% for
EVAR, respectively (P  .66).
Endoleak. Eight of 41 patients (20%) with stent grafts
had endoleak at the time of the last imaging study (median,
1.6 years; range, 1.7 month-4.8 years). There were four
type II endoleaks, three small distal type I endoleaks, and
one endoleak of unknown origin.
Reinterventions. During a mean follow-up of 5.4
years (range, 1 month-19.9 years), 43 patients (10%) un-
derwent 51 reinterventions (OR, 35 [9%]; EVAR, 8,
neurysms in 72 patientsa
te in cm/y (number of aneurysms)
3.0-3.4 (31) 3.5 (22) Overall (104)
0.31 (26) 0.30 (20) 0.27 (94)
0.36 (5) 1.78 (2) 0.40 (10)
0.32 0.31 0.29
iliac artery aneurysms
Group 2, No. (%) Group 3, No. (%) Overall, No. (%)
15 46 438
8 (53) 28 (61) 313 (71)
7 (47) 18 (39) 125 (29)
3 (20) 6 (13) 70 (16)
2 (13) 9 (20)a 33 (8)
1 (4)b 8 (14)b 62 (9)b
0 1 (7) 7 (2)
4 (27) 5 (11) 45 (10)c
4 (27)a 4 (9) 22 (5)
0 0 20 (4)
0 1 (2) 3 (1)d
, CIAA with current or previously repaired AAA; Group 2, CIAA with IIAA;
715.
red.ery a
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roup 1
verall,[18%], P  .06), of which 25 were vascular and 26 nonva-
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2% (89%  2% for vascular and 87%  2% for nonvascular
complications). There was no difference among groups or
between OR and EVAR at 3 years (all-cause, 83%  2% vs
69%  9%, P  .17; vascular, 92%  2% vs 79%  8%; P 
.13; Appendix Fig 3, online only). Freedom from reinter-
ventions was higher in patients with elective vs emergency
repair after OR at 2 years (all-cause: 87% 2% vs 72% 8%,
P  .002; vascular: 95%  1% vs 82%  7%, P  .003).
There was no difference in graft patency or reinterven-
tions in patients who underwent OR before or after the
endovascular era (1986-2000: 312 patients, 503 CIAAs;
2001-2005: 82 patients, 145 CIAAs).
Buttock claudication. Buttock claudication was re-
ported in 36 of the 433 survivors (8%). The incidence was
Table IV. Early complications
Complications
Open repair (n 
No. (%)
Elective E
Patients, No. 353
Systemic morbidity
Cardiac complications 38 (11) 1
Myocardial infarction 6 (2)
Pulmonary complications 46 (13) 1
Pneumonia 21 (6) 1
Pulmonary embolism 3 (1)
Renal complications 14 (4)
Acute renal failure 4 (1)
Ileus 17 (5)
Deep vein thrombosis 6 (2)
Lower limb ischemia 6 (2)
Ischemic colitis requiring operation 2 (1)
Wound complications
Wound infection 6 (2)
Wound Dehiscence 10 (3)
Graft failure 2 (1)
Total 345
aFive intraoperative deaths were excluded.
bP  .05 vs elective repair.
cP  .05 vs open repair.
Fig 2. Kaplan-Meier analysis shows survival of 438 patients after
open (OR) and endovascular (EVAR) repair of common iliac
artery aneurysms. The dotted line indicates standard error 10%.5% (21 of 389) after OR and 34% (15 of 44) after EVAR(P  .001). The incidence in OR patients was 27% (26 of
98, per limb) in those who underwent IIA ligation. In nine
patients with bilateral IIA ligation, five had bilateral and
two had unilateral buttock claudication; only two were
asymptomatic. In 35 patients with IIA or IIAA emboliza-
tion, buttock claudication was present in 15 of 33 patients
(45%, per limb). There was no significant difference in
buttock claudication between patients with IIA ligation
and those with IIA embolization (P  .05).
Most patients reported improvement in symptoms dur-
ing follow-up examinations, and no patient required addi-
tional intervention for claudication.
DISCUSSION
CIAAs occur most frequently in elderly men. The prev-
alence of male patients ranges from 81% to 100%, with a
mean age between 62 and 75 years.1,4,8,9,13,23,26 About
20% of patients with AAA have a CIAA,27 and isolated
CIAAs are rare. In a Danish study that screened 4176 men
for AAA, the prevalence of CIAA3.5 cm in men between
the ages of 65 and 73 was 0.17%; isolated CIAAs occurred
in 0.05%.28
Patients with CIAAs frequently have aortic and other
IAAs. Richardson and Greenfield9 observed multiple aneu-
rysms in 67% of the patients with IAAs. In our series, 86% of
the patients with CIAA had AAA and 65% had contralateral
CIAA. Isolated CIAAs had less (26%) contralateral CIAAs
than those with associated AAA (70%). Most CIAAs are
degenerative atherosclerotic aneurysms; inflammatory an-
eurysms have been observed in 3% to 19% of the cases.29-31
Growth of CIAAs has been frequently unpredictable.
Kasirajan et al32 noted no growth of seven isolated CIAAs,
), Endovascular repair
(n  44), No. (%)
Overall, No. (%)ncy Elective Emergency
43 1 433a
)b 2 (5) 0 52 (12)
)b 0 0 11 (3)
)b 0c 0 65 (15)
)b 0 0 33 (8)
0 0 4 (1)
)b 0 0 20 (5)
)b 0 0 8 (2)
) 0 0 21 (5)
0 0 8 (2)
0 0 7 (2)
b 0 0 4 (1)
b 1 (2) 0 10 (2)
1 (2) 0 13 (3)
2 (5) 0 4 (1)
40 1 422389a
merge
36a
2 (33
5 (14
9 (53
2 (33
1 (3)
6 (17
4 (11
4 (11
2 (6)
0
2 (6)
3 (8)
2 (6)
0
34measuring 2 to 2.5 cm in diameter,monitored for 50months.
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and no expansion of the aneurysms was recorded in 37.5%;
those3 cm in size grew at an average of 2.6 mm/y.Median
growth rate in our study was 0.29 cm/y, and those3 cm in
size grew by 3.2 mm/y. Hypertension was correlated with
growth. Limitations of our data are that expansion rate could
only be measured in 15% of the treated iliac aneurysms (n 
104). However, 51% of aneurysms (n  53) in our series
monitored for growth were 3 cm; whereas in the Santilli
series, 12% (n 40) were3 cm, a variable likely responsible
for the different findings.
A 3-cm CIAA has been considered for repair by most
authors because of an increasing risk of developing symp-
toms, including rupture of the aneurysm.1,4,6,8-10,28,32-34
Most ruptured IAAs are usually much larger, however.
McCready et al1 noted mean size of both symptomatic and
ruptured IAAs was 7.8 cm. Lowry and Kraft3 found mean
diameter of ruptured IAAs was 7.5 cm, and Richardson and
Greenfield9 observed that sizes of ruptured IAAs ranged
from 3.5 to 18 cm. In our series, the median diameter of
ruptured CIAA was 6 cm, three were 5 cm, and no
aneurysm 3.8 cm in diameter ruptured. It appears that
asymptomatic CIAAs 3.5 cm in size can be safely ob-
served. This number in high-risk patients can be 4 cm, as
suggested by Santilli et al.4
IAAs are frequently symptomatic, and the risk of rupture
in series with isolated IAAs was high. In a review of the
literature that included 367 patients with 500 isolated IAAs,
Krupski et al8 found 62% were symptomatic and 29% rup-
tured. Symptoms include right lower quadrant pain, renal
dysfunction, DVT, and rectal or perineal pain. Thrombosis
and embolism will result in hip or leg claudication. In our
series, 29% of CIAAs were symptomatic and 5% ruptured.
Patients with isolated CIAAs had a 9% risk of rupture.
A CIAA rupture is usually a life-threatening emergency
that can lead to hemorrhagic shock and death without inter-
vention. Rupture of an associated AAA can also occur in
patientswithCIAA, as it did in half of the patientsweoperated
on emergently. Rupture of the CIAA into the iliac vein or
inferior vena cava results in AVF, and some of these without
retroperitoneal hemorrhage occasionally remain stable for
days or evenweeks. Presentations include lower limb swelling,
a continuous abdominal bruit, abdominal pain, decreased
pedal pulses, heart failure, and renal dysfunction. On CT
angiography, immediate filling of dilated iliac veins and the
inferior vena cava is evident. Open repair includes control of
the fistula from within the sac of the aneurysm with digital
compression, avoiding pulmonary embolization of debris
from the aneurysm sac (Fig 3).Venous bleeding canusually be
controlled with a balloon catheter for direct suture closure of
the defect, and the aneurysm is repaired with a prosthetic
graft.35 Successful repair of abdominal AVF with EVAR
has also been reported.36-38
Open repair of CIAA includes the use of bifurcated or
straight polyester grafts placed through a transperitoneal or
retroperitoneal approach. Open repair can be challenging
because of previous abdominal surgery or deep location of
the aneurysm, especially in obese patients. Before OR ofinflammatory aneurysms, placement of ureteral stents is
helpful. Simultaneous AAA, CIAA, and IIAA repair is
performed if concomitant aneurysms are present. Preserva-
tion of flow through at least one IIA is important and is
done using an interposition graft from the iliac limb of the
polyester graft. If the IIAs have to be oversewn, or unilat-
eral ligation is performed in the face of contralateral IIA
occlusion, reimplantation of the IMA into the aortic graft is
advised. Unfortunately, collateral circulation may not al-
ways be sufficient to prevent ischemic colitis despite IMA
reimplantation, as was the case in two of our patients.
Results of ORs have continuously improved in the past
decades. In a collected series of 320 operations performed
between 1985 and 2001, mortality in elective repair was
5%, with an emergencymortality rate of 40%.26 In a seminal
paper onOR of 19 isolated IAAs, Krupski et al8 reported no
deaths and a single major complication (5%). Our series of
438 patients had an elective mortality rate of 1%, but major
complication rates were high at 23%. Mortality for emer-
gency OR was 27%. Correct early diagnosis, preoperative
planning and a systematic open operative approach that
includes retroperitoneal repair for unilateral disease, revas-
cularization of at least one IIA, and the liberal use of IMA
reimplantation, as suggested by Krupski,8 can decrease the
risk of complications.
No deaths occurred in our patients who underwent OR
for AVF. Because most aortocaval or ilioiliac AVFs are
caused by unusually large aneurysms, palpation of the infe-
rior vena cava or iliac veins before aortic cross clamping is
strongly advised: a thrill indicates arteriovenous shunting.
Endovascular repair has emerged as a safe and mini-
mally invasive technique for repair of CIAAs. It has become
an attractive, low-risk option for those who are anatomi-
Fig 3. Drawing shows open repair of an ilioiliac arteriovenous
fistula.A,Digital compression of the fistula controls venous bleed-
ing. B, Placement of a venous thrombectomy catheter and suture
closure of the fistula before graft repair.cally suitable for stent graft repair and do not present with
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stent graft repair with embolization of the IIA or the IIAA.
Durability, anastomotic endoleak, stent graft thrombo-
sis, high cost, andmaintaining circulation to the IIA remain
potential problems. The rate of perioperative complications
in a recent review was 20% (range, 10%-32%). Anastomotic
endoleak occurred in 4% of the patients.26 In a series of 28
isolated IAAs treated with EVAR, Parsons et al39 reported
four (12%) complications, that included embolization (n
1), wound dehiscence (n  2), and mucosal ischemia (n 
1). One late rupture required conversion to OR. Patency at
3 years was 86%.
Concerns about the need to occlude the IIA during
EVAR have been raised by Krupski et al8 since amulticenter
study reported a technical failure rate of 19% and an adverse
event rate of 27%.40 Results in the past decade, however,
improved continuously, and a review of 117 isolated
IAAs26 treated with EVAR in 106 patients revealed a 1%
mortality rate, with no deaths reported in studies published
after 1996. We had no deaths and found shorter ICU and
hospital lengths of stay and fewer major complications after
EVAR than after OR. At 3 years, the reintervention rate was
not higher after EVAR, similar to the results found by
others,22 and there was no survival advantage for OR.
Embolization of unilateral IIA can be performedwith low
risk of serious adverse effects, although the high incidence of
buttock claudication after EVAR, which was 45% in our
patients and31% in another recent series,22 remains a concern.
Most patients, however, tolerate symptoms well and improve
with time, even to a degree of resolution of symptoms.22 The
incidence of buttock claudication and pelvic ischemic compli-
cations after bilateral IIA occlusion is very high,8,40 however,
and patients with a contralateral IIA who are treated with
EVAR should also undergo ipsilateral IIA revascularization
using either endovascular or open surgical techniques, such as
retroperitoneal IIA bypass using the common femoral or EIA
as inflow. Early results of branched stent graft repairs of IAAs
have been published,13,16,19-23,34,39,40 andmore frequent use
of these devices to assure pelvic perfusion can be expected in
the future.
It is also noteworthy that IIA revascularization cannot
always be performed during OR: one-third of our patients
did not undergo IIA revascularization. When a patent
ipsilateral iliac artery was ligated during surgery, the inci-
dence of buttock claudication was 27%.
Endovascular repair for ruptured CIAAs is attractive
and it is easy to predict that this will be the procedure of
choice in anatomically suitable patients. At this time, OR is
themain treatment option of CIAAs that cause compressive
symptoms because most IAAs do not decrease in size after
EVAR.39
Our review has the usual limitations of a large retro-
spective study. This is a single-center experience with
CIAAs, including those who presented with associated
AAAs. It was interesting to note, however, that subgroup
analysis did not reveal differences in complications or sur-
vival of patients with or without AAA.CONCLUSION
Our study confirmed that CIAAs are frequently associ-
ated with AAAs.We found the expansion rate of CIAAs was
0.29 cm/y and hypertension predicted faster expansion.
Because no rupture of a CIAA 3.8 cm was observed,
elective repair of good risk asymptomatic patients with
CIAA 3.5 cm is justified. Both OR and EVAR can be
performed with low mortality in elective patients, but early
complications and hospital days are higher after OR than
after EVAR. Survival and reintervention rates were similar
between OR and EVAR at 3 years. Although the high
incidence of buttock claudication after EVAR remains a
concern, these data support EVAR as a first-line treatment
for most anatomically suitable patients who require repair
of CIAA. Patients with compressive symptoms or those
with AVF should preferentially be treated with OR.
We thank Dr. Haraldur Bjarnason for his participation
in some of these operations, Kristine Thomsen for her data
analysis, and Marcia Simonson for her assistance.
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Dr Richard Cambria (Boston, MA). Dr Huang, Dr Gloviczki,
congratulations on a great series. Obviously, the ProgramCommittee
was impressed. It’s one of the largest series that I know of in the
literature. And I’m happy to comment, since some of your data
reinforces my biases. Over the years seeing patients who had been
recommended to have repair of 25-mm iliac aneurysms is, of course, a
common observation in vascular surgeons’ offices. So I have a ques-
tion. And your talk, of course, was beautifully illustrated. I predict that
the finger in the fistula slide will become a classic.
My question is about your conclusion. Your conclusion was
that repair of aneurysms greater than 3.5 cm is justified. My bias
about these aneurysms, that they generally tend to be large before
they rupture, is I think corroborated by your data. So what will be
your take-home message about a recommendation for size thresh-
old for repair?
DrPeterGloviczki:Thank you verymuch, Dr Cambria. Youraneurysms that ruptured were greater than 5 cm in size. So we tried
to define in our experience and in the literature what would be the
size in good-risk asymptomatic patients that warrant repair. And
since, again, we found no ruptures in aneurysms less than 3.8 cm in
size, but we found an aneurysm, and others have found an aneu-
rysm, in that size range, that’s why we think that the original data
that was recommended by Dr Santilli of 3.5 cm can be currently
accepted as a critical size for good-risk surgically fit patients for
repair of common iliac artery aneurysms.
Dr Anil Hingorani (Brooklyn, NY). Did you notice any
external iliac artery aneurysms in your series? Because they have
been reported very rarely in the literature.
Dr Gloviczki: We had 11 patients in this series in whom the
diagnosis of external iliac artery aneurysmwas given.Most of them,
frankly, were extensions of common iliac artery aneurysms; there-
fore, we just decided, as many did in the literature, to disregard
patients who had external iliac artery aneurysm.
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aneurysm with a common iliac artery aneurysm but had an external
iliac aneurysm. So I would say external iliac artery aneurysm
continues to be very rare. Some of them are false aneurysms after a
previous repair, but we did not specifically actually look at them
because of the very small group.
Dr Daniel Reddy (Detroit, Mich). Particularly with this large
experience with iliac aneurysms, I am interested to hear whether
the patients experienced any buttock claudication, particularly in
the more recent patients, that may have had embolization.
Dr Gloviczki: That is an excellent point, because obviously
that is why you may think that an open repair would be better for
your patients than an endovascular repair.
We had many surprises when we looked up the data of this
study. And one of them was clearly that we found actually pretty
high number of buttock claudication in those patients, too, who
underwent open repair. Open repair doesn’t necessarily mean that
your patient had internal iliac artery revascularization. Indeed, 29%
of the open repair had ipsilateral internal iliac artery ligated at some
level.
So buttock claudication was significant. But again, you are
treating your patient with a potentially life-threatening condition,
and you have to make a decision whether buttock claudication is a
reasonable alternative to risk of the rupture. And usually it is.
One-third of the patients who underwent ligation—and we
had follow-up information almost of 100 patients—had buttock
claudication who had ligation of the ipsilateral internal iliac artery.
Patients who had bilateral internal iliac artery ligation had buttock
claudication in 80%. About 45% of our patients who underwent
endovascular repair with embolization had some degree of buttock
claudication. So buttock claudication continues to be a problem.
And I think, therefore, investigation to revascularize the internal
iliac artery with endovascular technique should be continued.
Dr Steven Rivers (Bronx, NY). It seems like most of the
patients did have associated more generalized aneurysmal disease.And I would assume that the treatment selection and the results
were dictated largely, I mean not exclusively, but to some degree
by the presence or absence of the abdominal aortic aneurysm
component.
My question is, what is the current approach at the Mayo
Clinic for a patient who presents with an asymptomatic isolated
iliac artery aneurysm, would you recommend endografting as your
first-choice procedure or would you still recommend open repair in
a patient who was both physiologically and technically feasible for
either modality?
Dr Gloviczki: I think you bring up an excellent point that,
indeed, more than 80% of the patients have associated aortic
aneurysms. Now, we decided to include only those patients from
that group who had large, greater than 3.5 cm, iliac artery aneu-
rysms. And one of the reasons is that we didn’t want Dr Huang to
review several thousands of patients who had smaller iliac artery
aneurysms. So that is the comment on the combined group.
Patients who have isolated iliac artery aneurysms currently, I
would say, based on the data that we have, we strongly consider
offering as a first line of treatment endovascular repair. But we also
will take into consideration the associated aneurysms. We take into
consideration the data that are available out there for aortic aneu-
rysms. But more so for iliac than for aortic aneurysm do we now
consider endovascular repair as the primary treatment.
Dr Harry Schanzer (New York, NY). In the patients that
have the unilateral common iliac aneurysm and you are planning an
endovascular repair, how often do you put a single tube or you
have to go for a bifurcation?
Dr Gloviczki: As you could see, we only had 8 patients who
had a single tube. And of the 8, we only had 2 where we could place
this tube into the common iliac artery. So I would suggest that it’s
rare that you have a suitable or excellent proximal and distal
endings in the common iliac artery. In 75% we have to go into the
external iliac artery and, again, over 80% will require bifurcated
repair.
hazard ratio.
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June 20081211.e1 Huang et alAppendix Table I (online only). Size distribution of 668
Presentation Total
2.4 cm,
No. (%)
2.5-2.9 cm,
No. (%)
3.0-3
No
Asymptomatic 495 41 (8) 47 (9) 46
Symptomatica 158 8 (5) 14 (9) 19
Rupture 15 0 0
Totalc 668 49 (7) 61 (9) 65
aP  .79 vs asymptomatic presentation.
b3.8 cm.
cSizes of 47 common iliac artery aneurysms were not available.common iliac artery aneurysms
.4 cm,
. (%)
3.5-3.9 cm,
No. (%)
4.0-4.4 cm,
No. (%)
4.5-4.9 cm,
No. (%)
5 cm,
No. (%)
(9) 106 (21) 108 (22) 45 (9) 102 (21)
(12) 33 (21) 33 (21) 14 (9) 37 (23)
0 1b (7) 1 (7) 1 (7) 12 (80)
(10) 138 (21) 143 (21) 61 (9) 163 (24)Appendix Table II (online only). Univariate analysis of
risk factors predicting survival for 438 patients with
common iliac artery aneurysms repair
Variable HR 95% CI P
CIAA rupture 2.81 1.76-4.50 .001
Urgency (elective vs emergency) 2.37 1.63-3.44 .001
COPD 1.87 1.43-2.44 .001
High surgical risk 1.60 1.21-2.11 .001
Age 73 y (median) 1.50 1.16-1.93 .002
Age, per 1 year 1.04 1.02-1.06 .001
Diabetes mellitus 1.41 0.96-2.06 .08
Coronary artery disease 1.21 0.94-1.56 .14
AAA rupture 1.10 0.60-2.01 .77
Concomitant or repaired AAA 1.06 0.75-1.51 .73
Sex (male vs female) 1.02 0.60-1.72 .94
AAA, abdominal aortic aneurysm; CI, confidence interval; CIAA, common
iliac artery aneurysm; COPD, chronic obstructive pulmonary disease; HR,
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Volume 47, Number 6 Huang et al 1211.e2Appendix Fig 1 (online only). Primary graft patency of 627
open emergency and elective common iliac artery aneurysm re-
pairs. The dotted line indicates standard error 10%.Appendix Fig 2 (online only). Primary patency of 691 common
iliac artery aneurysm repairs CIAA repairs by open (OR) vs endo-
vascular (EVAR) techniques. The standard error10% for all data
points.Appendix Fig 3 (online only). Freedom from reinterventions for
patients undergoing open (OR) and endovascular aneurysm repair
(EVAR). Standard error 10% for all data points.
